EUVIMEDEUVIMED entdecken
Crossref

Qianggu Decoction Alleviated Osteoporosis by Promoting Osteogenesis of BMSCs through Mettl3‐Mediated m 6 A Methylation

Yuchen Wang iD, Weizhong Yu, Yuan E, Lining Rui, Chuan Jia, Wenke Zhu

Advanced Biology · 2024

DOI: 10.1002/adbi.202400341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Biology, 2024. Verfasst von Yuchen Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Wujin TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Changzhou, Jiangsu, 213161, China. Hauptthemen laut MEDLINE: Osteogenesis, Mesenchymal Stem Cells, Osteoporosis, Rats, Sprague-Dawley. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Jiangsu Traditional Chinese Medicine Sci&Tech Program, Changzhou Sci&Tech Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoporosis development is linked to abnormal bone marrow mesenchymal stem cells (BMSCs) differentiation. N6‐methyladenosine (m 6 A), a prevalent mRNA modification, is known to influence BMSCs' osteogenic capacity. Qianggu decoction (QGD), a traditional Chinese medicine for osteoporosis, has unknown effects on BMSCs differentiation. This study investigates QGD's impact on BMSCs and its potential to ameliorate osteoporosis through m 6 A regulation. Using Sprague‐Dawley (SD) rats with ovariectomy‐induced osteoporosis, it is evaluated QGD's antiosteoporotic effects through micro‐CT, histology, Western blotting, and osteoblastogenesis markers. QGD is found to enhance bone tissue growth and upregulate osteogenic markers Runx2, OPN, and OCN. It also promoted BMSCs osteogenic differentiation, as shown by increased calcium nodules and ALP activity. QGD treatment significantly increased m 6 A RNA levels and Mettl3 expression in BMSCs. Silencing Mettl3 with siRNA negated QGD's osteogenic effects. Collectively, QGD may improve BMSCs differentiation and mitigate osteoporosis, potentially through Mettl3‐mediated m 6 A modification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteogenesisMesenchymal Stem CellsOsteoporosisRats, Sprague-DawleyDrugs, Chinese HerbalMethyltransferasesCell DifferentiationAdenosineAnimalsRatsFemaleMethylationOvariectomy

Stichwörter der Autor:innen

Mettl3Qianggu decoctionRunx2bone marrow mesenchymal stem cellsm6A modification

Substanzen

Drugs, Chinese HerbalMethyltransferasesAdenosineN-methyladenosine

Autor:innen und Institutionen

  • Department of Orthopedics, Wujin TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Changzhou, Jiangsu, 213161, China.

ORCID-Profile: Yuchen Wang

Förderung

  • Jiangsu Traditional Chinese Medicine Sci&Tech Program
  • Changzhou Sci&Tech Program

Zitieren

APA

Wang, Y., Yu, W., E, Y., Rui, L., Jia, C., & Zhu, W. (2024). Qianggu Decoction Alleviated Osteoporosis by Promoting Osteogenesis of BMSCs through Mettl3‐Mediated m 6 A Methylation. Advanced Biology. https://doi.org/10.1002/adbi.202400341

Vancouver

Wang Y, Yu W, E Y, Rui L, Jia C, Zhu W. Qianggu Decoction Alleviated Osteoporosis by Promoting Osteogenesis of BMSCs through Mettl3‐Mediated m 6 A Methylation. Advanced Biology. 2024. doi:10.1002/adbi.202400341

BibTeX
@article{Wang2024,
  author = {Wang, Yuchen and Yu, Weizhong and E, Yuan and Rui, Lining and Jia, Chuan and Zhu, Wenke},
  title = {Qianggu Decoction Alleviated Osteoporosis by Promoting Osteogenesis of BMSCs through Mettl3‐Mediated m 6 A Methylation},
  journal = {Advanced Biology},
  year = {2024},
  doi = {10.1002/adbi.202400341}
}
Kostenlos starten →